Abstract
The synthesis of novel benzimidazole derivatives with varied carbon chain length was achieved via “one-pot” nitro reductive cyclization (6a–o). In each case, compounds were determined by the elemental analyses, FT-IR, mass, 1H and 13C NMR spectroscopy. Further, these derivatives were screened for their in vitro anticancer, in vitro and in vivo anti-inflammatory activities. The results revealed that the length of the carbon chain greatly affects the activity. Among the 15 derivatives, compound 6d induced maximum cell death in HeLa and A549 cell lines and compound 6a emerged as a potent anti-inflammatory agent. Also, the physicochemical properties of potent compounds were studied.
Similar content being viewed by others
References
J. Camacho, A. Barazarte, N. Gamboa, J. Rodrigues, R. Rojas, A. Vaisberg, R. Gilman, J. Charris, Bioorg. Med. Chem. 19, 2023 (2011)
E. Menteşe, F. Yılmaz, M. Emirik, S. Ülker, B. Kahveci, Bioorg. Chem. 76, 478 (2018)
J.R. Kumar, L. Jawahar, D.P. Pathak, E-J Chem 3, 278 (2006)
M. Tonelli, M. Simone, B. Tasso, F. Novelli, V. Boido, F. Sparatore, G. Paglietti, S. Pricl, G. Giliberti, S. Blois, C. Ibba, Bioorg. Med. Chem. 18, 2937 (2010)
C. Kus, G. Ayhan-Kilcigil, B.C. Eke, Arch. Pharmacal Res. 27, 156 (2004)
M. Abdel-Motaal, K. Almohawes, M.A. Tantawy, Bioorg. Chem. 101, 103972 (2020)
M. Rashid, Bioorg. Chem. 96, 103576 (2020)
M. Dmitryjuk, M. Szczotko, K. Kubiak, R. Trojanowicz, Z. Parashchyn, H. Khomitska, V. Lubenets, Pharmaceuticals 13, 332 (2020)
M. Srinivas, S. Satyaveni, B. Ram, Russ. J. Gen. Chem. 88, 2653 (2018)
C. Karthikeyan, V.R. Solomon, H. Lee, P. Trivedi, Arab. J. Chem. 10, S1788 (2017)
S. Tahlan, S. Kumar, S. Kakkar, B. Narasimhan, BMC Chem. 13, 1 (2019)
S.E. Waggoner, Lancet 361, 2217 (2003)
J.D. Minna, J.A. Roth, A.F. Gazdar, Cancer Cell 1, 49 (2002)
A. Kamal, G.B. Kumar, V.L. Nayak, V.S. Reddy, A.B. Shaik, M.K. Reddy, MedChemComm 6, 606 (2015)
I. Dogliotti, S. Ragaini, F. Vassallo, E. Boccellato, G. De Luca, F. Perutelli, C. Boccomini, M. Clerico, B. Botto, D. Grimaldi, L. Orsucci, J. Pers. Med. 11, 249 (2021)
L.M. Wagner, Onco Targets Ther. 8, 1931 (2015)
B. Moldoveanu, P. Otmishi, P. Jani, J. Walker, X. Sarmiento, J. Guardiola, M. Saad, J. Yu, J. Inflamm. Res. 2, 1 (2009)
E. Ricciotti, G.A. FitzGerald, Arterioscler. Thromb. Vasc. Biol. 31, 986 (2011)
A. Almasirad, Z. Mousavi, M. Tajik, M.J. Assarzadeh, A. Shafiee, DARU J. Pharm. Sci. 22, 1 (2014)
C. Sostres, C.J. Gargallo, A. Lanas, Arthritis Res. Ther. 15, 1 (2013)
R. Sathyanarayana, V. Kumar, G.H. Pujar, B. Poojary, M.K. Shankar, S. Yallappa, J. Photochem. Photobiol. A 401, 112751 (2020)
R. Sathyanarayana, B. Poojary, R.B. Chandrashekarappa, H. Kumar, V.K. Merugumolu, J. Chin. Chem. Soc. 67, 1501 (2020)
T. Mosmann, J. Immunol. Methods. 65, 55 (1983)
J. Fernandes, B.C. Revanasiddappa, K. Ishwarbhat, M.V. Kumar, L. D’Souza, S. Smithaalva, Res. J. Pharm. Technol. 10, 1679 (2017)
C.A. Winter, E.A. Risley, G.W. Nuss, Exp. Biol. Med. 111, 544 (1962)
OECD, Test No. 425: Acute Oral Toxicity: Up and Down Procedures. OECD Guidelines for the Testing of Chemicals, OECD, Paris 2001.
C.A. Lipinski, F. Lombardo, B.W. Dominy, P.J. Feeney, Adv. Drug. Deliv. Rev. 23, 3 (1997)
A.A. Magda, N.I. Abdel-Aziz, A.M. Alaa, A.S. El-Azab, K.E. ElTahir, Bioorg. Med. Chem. 20, 3306 (2012)
M.A. Alkhader, R.C. Perera, R.P. Sinha, R.K. Smalley, J. Chem. Soc. Perkin Trans. I 1, 1056 (1979)
V. Kumar, G. Basavarajaswamy, M.V. Rai, B. Poojary, V.R. Pai, N. Shruthi, M. Bhat, Bioorg. Med. Chem. 25, 1420 (2015)
M.İ Han, H. Bekçi, A. Cumaoğlu, ŞG. Küçükgüzel, Marmara. Pharm. J. 22, 559 (2018)
Acknowledgements
The author thank DST/KSTePS, Karnataka, for providing Ph.D. Fellowship and thankful to DST-PURSE Laboratory, Mangalore University.
Funding
This research was funded by DST/KSTePS through fellowship (DST/KSTePS/Ph.D.Fellowship/CHE-07:2019-20/462/2).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
The experimental protocols according to the CPCSEA guidelines and IAEC clearance were taken prior to the commencement of the study. The animal treatment protocol was approved by Reg. No. NGSM/IAEC/March-2019/129.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Sathyanarayana, R., Poojary, B., Srinivasa, S.M. et al. In vitro, in vivo and in silico-driven identification of novel benzimidazole derivatives as anticancer and anti-inflammatory agents. J IRAN CHEM SOC 19, 1301–1317 (2022). https://doi.org/10.1007/s13738-021-02381-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13738-021-02381-y